Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
Company profile
Ticker
MAYNF, MAYND
Exchange
Website
CEO
Scott Richards
Employees
Incorporated
Location
Fiscal year end
SEC CIK
MAYNF stock data
Latest filings (excl ownership)
Latest ownership filings
4
Inhibitor Therapeutics, Inc.
19 Jan 21
4
Inhibitor Therapeutics, Inc.
20 Jul 20
4
HedgePath Pharmaceuticals, Inc.
24 Jan 19
4
HedgePath Pharmaceuticals, Inc.
19 Dec 18
4
HedgePath Pharmaceuticals, Inc.
6 Jul 18
4
HedgePath Pharmaceuticals, Inc.
12 Feb 18
4
HedgePath Pharmaceuticals, Inc.
11 Jan 18
4
HedgePath Pharmaceuticals, Inc.
15 Nov 16
4
HedgePath Pharmaceuticals, Inc.
7 Nov 16
4
HedgePath Pharmaceuticals, Inc.
27 May 16